NIH-funded research R01 grant

Understanding how tumors interact with immune cells in their environment

Official title: Modeling and targeting tumor-immune signaling interactions in tumor microenvironment

Funded at Washington University · NIH-11030855 · Data updated 2026-11-12

This study is looking at how cancer cells and immune cells interact in the area around tumors to find new ways to improve cancer treatments, and it could help patients by discovering better options for fighting their cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startMay 16, 2023
Project endFebruary 28, 2027
Funding year2025
Award (this year)$314,887
NIH project number5R01LM013902-03
Project IDNIH-11030855 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with various types of cancer who are undergoing treatment or are interested in novel therapeutic approaches.

Less likely to help

Patients with non-cancerous conditions or those not currently receiving cancer treatment may not benefit from this research.

What this research studies

This research investigates the complex interactions between tumors and immune cells within the tumor microenvironment (TME), which are crucial for tumor growth and response to therapies. By utilizing advanced technologies such as single-cell RNA sequencing and artificial intelligence models, the study aims to identify new molecular targets that can disrupt harmful signaling between tumor and immune cells. The approach includes creating 3D models of tumor environments and using genetic techniques to better understand these interactions. Patients may benefit from insights that could lead to more effective cancer treatments.

Why it matters

Potential benefit: If successful, this research could lead to the development of new therapies that improve cancer treatment outcomes by targeting tumor-immune interactions.

How similar studies have gone: Other research has shown promise in using similar technologies to understand tumor-immune interactions, indicating potential for success in this approach.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Li, Fuhai — Washington University
  • Study coordinator: Li, Fuhai

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.